Law 3/2026 modifies the regulations regarding the neonatal screening program (heel prick test) to strengthen the detection of rare diseases within the National Health System. The law aims to guarantee timely and equitable diagnosis, aligning with World Health Assembly recommendations to integrate these pathologies into state health planning. The objective is to detect pathologies before clinical symptoms appear to prevent premature mortality and disabilities.
For newborns and their families, the regulation improves healthcare safety by expanding the detection of rare diseases through universal screening. For Autonomous Communities and the National Health System, it entails the obligation to coordinate and standardise screening processes to eliminate existing territorial disparities resulting from decentralisation. The clinical impact lies in the early activation of healthcare and treatment pathways for conditions affecting fewer than five cases per 10,000 inhabitants.
The administrative team reviews your specific situation.